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Abstract
Background: Primary care needs to be patient-centered, integrated, and interprofessional to help patients with complex needs
manage the burden of medication-related problems. Considering the growing problem of polypharmacy, increasing attention has
been paid to how and when medication-related decisions should be coordinated across multidisciplinary care teams. Improved
knowledge on how integrated electronic health records (EHRs) can support interprofessional shared decision-making for medication
therapy management is necessary to continue improving patient care.
Objective: The objective of our study was to examine how physicians and pharmacists understand and communicate
patient-focused medication information with each other and how this knowledge can influence the design of EHRs.
Methods: This study is part of a broader cross-Canada study between patients and health care providers around how
medication-related decisions are made and communicated. We visited community pharmacies, team-based primary care clinics,
and independent-practice family physician clinics throughout Ontario, Nova Scotia, Alberta, and Quebec. Research assistants
conducted semistructured interviews with physicians and pharmacists. A modified version of the Multidisciplinary Framework
Method was used to analyze the data.
Results: We collected data from 19 pharmacies and 9 medical clinics and identified 6 main themes from 34 health care
professionals. First, Interprofessional Shared Decision-Making was not occurring and clinicians made decisions based on their
understanding of the patient. Physicians and pharmacists reported indirect Communication, incomplete Information specifically
missing insight into indication and adherence, and misaligned Processes of Care that were further compounded by EHRs that are
not designed to facilitate collaboration. Scope of Practice examined professional and workplace boundaries for pharmacists and
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physicians that were internally and externally imposed. Physicians decided on the degree of the Physician-Pharmacist Relationship,
often predicated by colocation.
Conclusions: We observed limited communication and collaboration between primary care providers and pharmacists when
managing medications. Pharmacists were missing key information around reason for use, and physicians required accurate
information around adherence. EHRs are a potential tool to help clinicians communicate information to resolve this issue. EHRs
need to be designed to facilitate interprofessional medication management so that pharmacists and physicians can move beyond
task-based work toward a collaborative approach.
(JMIR Hum Factors 2018;5(3):e24)  doi: 10.2196/humanfactors.9891
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Introduction
In clinical settings, medication-related decisions are often passed
verbally among patients, doctors, nurses, and pharmacists, and
the message can become distorted. Too often, however, critical
information is not shared, even when an electronic health record
(EHR) is used, and the decision to prescribe or not prescribe,
to take or not take a medication, is made with missing or
distorted information [1-4]. Health systems now promote an
ethos of partnership where providers and patients navigate
complex relationships and interactions. The shift from a
patient-physician decision-making dyad to a network of
providers introduces more complexity into what are often
byzantine processes that precede health decisions. Nevertheless,
patients often rely on a trusted health care professional’s
(HCP’s) expertise to make important decisions where the
situation is emergent or ambiguous (eg, having a surgery or
starting a new medication) [5,6]. Research has not yet
empirically characterized how current communication between
health care practitioners affects care, and specifically how EHRs
can strengthen communication by making information easier
to access [7].
A medication-related decision involves, at minimum, a patient,
a prescriber, and a pharmacist, and all parties are engaged in a
process of shared decision-making (SDM) [8,9]. SDM is based
on a model of communication where HCPs and patients both
contribute to clinical decisions in unique ways [10,11]. The
HCPs share information about the benefits and risks of different
treatment options; the patients describe their preferences and
values as they relate to their treatment options. Interprofessional
shared decision-making (IP-SDM) involves multiple HCPs and
is emerging as a response to care increasingly being delivered
by interprofessional teams to collaboratively work with a patient
to decide on the best course of action [12]. A systematic review
of the adoption of SDM by HCPs concluded that while it is
unclear whether interventions that promote the adoption of SDM
are effective, interventions that target patients and HCPs
simultaneously are more effective than ones that only target
one group [13]. The evolution of IP-SDM is challenging our
beliefs about how and when HCPs actively communicate with
each other and with patients as well as about the role EHRs may
play in decision-making.
Adverse drug events (ADEs) are one of the outcomes of
miscommunication in the medication management process. The
costs of ADEs to the health care system are staggering, yet in
one US study, physician reviewers determined that of the 30%
inpatients who experienced ADEs, the events were preventable
in 44% cases [14-16]. While these medication-related problems
are the symptom of a complex and disconnect health care
system, the inclusion of pharmacists in medication management
has reduced the rates of ADEs as well as health care costs [17].
ADEs account for somewhere between 1.4% and 15.4% of
hospital admissions in the United States and Canada, accounting
for an estimated 177,504 emergency department visits by US
patients aged ≥65 years and increasing the mean length of
hospital stay from 8 to 20 days [18-20]. SDM is known to
improve communication, lessen ADEs, and, overall, lower
health care costs [21,22]. Through greater communication and
collaboration between HCPs and patients, IP-SDM provides a
platform that has significant potential to further lessen ADEs
and to continue lower health care costs [23].
In most health care settings, pharmacists and physicians often
do not communicate well because they largely work
independently and in parallel with each other, rather than
collaboratively [24]. Furthermore, there can be challenges in
communication due to differences of opinion on role, reluctance
to challenge, different work schedules, and different information
priorities [25-27]. For example, how physicians and pharmacists
communicate and make decisions with each other is based on
perceptions about the role each one plays in a person’s care and
is tightly tied to ideas about pharmacists’ scope of practice.
According to Nugus et al, there is a clear acknowledgment in
health care that physicians are the ones with “formal
responsibility of patient care” and that they are omnipresent in
care [28]. As a result, EHRs may reflect the physician’s
information or decision-making needs more than those of the
pharmacist or the patient. The challenge in designing
interdisciplinary EHRs is that they need to account for the
workflow and communication models of different professions.
It is important that physicians and pharmacists have a good
communication because it is essential to go beyond transactional
interactions to ensure optimal therapeutic outcomes for patients
[29]. This research has been conducted to better foundationally
understand how pharmacists and physicians communicate,
which can be used to lessen medication-related errors, lower
health care costs, and design and improve EHRs that facilitate
collaboration.
The objective of this exploratory study is to examine how
physicians and pharmacists understand and communicate
patient-focused medication information with each other and to
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identify barriers to IP-SDM for medication management that
should inform designing EHRs that support IP-SDM. This
research will allow for the design and refinement of EHRs that
can be designed to facilitate better communication, improve




This research was part of a larger mixed methods study on SDM
in the context of EHRs that included observations; interviews;
and think-aloud discussions with patients, primary care
physicians, and pharmacists. This paper focuses on qualitative,
semistructured interviews with physicians and pharmacists. We
have taken a pragmatic stance, recognizing that a constructivist
view of the truth can be tempered with the need to conduct
research that informs health care decision-making [30]. Our
analysis was guided by a framework analysis method that
provides both a systemic and flexible approach to
multidisciplinary data analysis [31].
We conducted interviews in community pharmacies and primary
care clinics across Canada using provinces to represent different
levels of primary care integration and adoption of EHRs (Table
1). This research received ethics approvals from the University
of Waterloo, the University of Alberta, Wilfrid Laurier
University, Université Laval, the University of Toronto, and
Dalhousie University.
Recruitment and Participants
The research team used a purposive sampling approach to
identify a broad spectrum of practice sites. Recruitment was
conducted through several venues including posters, social
media, and snowball sampling from previous and existing
contacts of the research team. We included pharmacists and
family physicians practicing in Ontario, Alberta, Quebec, and
Nova Scotia.
Data Collection
Three research assistants conducted and audiorecorded the
interviews. One of the research assistants was a PhD candidate
and experienced qualitative researcher (KM) and the other two
were PharmD students (KW, JB). The three interviewers jointly
conducted 3 interviews to train the student research assistants
in semistructured interview techniques, and they regularly met
throughout the data collection period to compare interview notes
and transcripts. All three research assistants interviewed
participants in Ontario, with KW completing all of the
interviews in Quebec and Alberta and JB completing all of the
interviews in Nova Scotia. Field notes recorded during and after
the interviews documented the environment, external influencers
or distractions, and participants; specific questions were added
to better understand the decision-making approach.
Table 1. Description of in-place electronic health records (EHRs) and primary care models in Alberta, Ontario, Quebec, and Nova Scotia between









Drug Information SystemPharmaceutical Information
Network
Integrated systems
Electronic prescriptionsAllergies, medical reports,
pathology and microbiology
results




drug alerts, allergies or intol-
erances, immunizations
Other information
YesYesYesYesPhysician access to EHR
YesNoDrug Information SystemeYesPharmacist access to EHR









aInformation collected in this table reflects health care at the time of the interviews and may have changed since.
bSHARE: Secure Health Access Record.
cSouth Western ON. EHRs are region specific in Ontario; separated into 3 regions.
dN/A: not applicable.
eAccess to laboratory values in near future.
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Interviews with HCPs consisted of two parts: (1)
medication-focused decision-making and (2) interviewee’s
opinion of EHRs. HCPs were interviewed where they practiced,
either in the pharmacy or the physician’s office. Interviews
focused on how the pharmacist or physician presented
information to patients; how collaboration was approached
during care, specifically in relation to medication prescribing
or problem solving; how they interacted with EHRs or electronic
medical records (EMRs) used in their practice; and finally
potential areas for developing new EHRs. The interview guide
is available in Multimedia Appendix 1.
Data Analysis
We employed a modified version of the Multidisciplinary
Framework Method to analyze the data [24]. A multidisciplinary
team, including engineers, clinicians, health researchers,
business and communication researchers, patients, and a patient
navigator, was involved in data analysis. The steps followed
were as follows: (1) interviews were transcribed verbatim; (2)
core research team members read the transcripts and listened
to the audiorecordings to familiarize themselves with the
interviews; (3) core team members thematically coded the data;
(4) the entire team thematically coded a subset of 5 interviews;
(5) the team codes were used to develop a working analytic
framework; (6) 2 team members (KM, KW) recoded the data;
and (7) finally, the data were presented to the entire team for
discussion and refinement. Data were stored, organized, and
reported using QSR NVIVO 11 Software (QSR International
Pty Ltd. Version 11, 2017). Any names and identifiers were
made anonymous in the transcription process. Multiple
triangulation of the data was achieved using a variety of
geographic sources, multiple coders, and a multidisciplinary
team of researchers interpreting the results [32].
Results
Study Population
In total, we interviewed 25 pharmacists and 9 family physicians
(Table 2). On average, the HCPs had been with their current
clinic for 8 years and had been practicing for 15 years.
Compared with physicians, a larger sample of pharmacists was
recruited to account for variability in practice setting; the latter
included pharmacists who worked in chain pharmacies (n=5),
independently owned pharmacies (n=12), and team-based
medical clinics (n=4).
Thematic Analysis
Initial coding conducted by the core research team led to the
identification of 46 codes, which were then developed into 5
themes describing the different elements of how pharmacists
and physicians make medication-related decisions with patients:
workflow, communication, accuracy, decision-making, and
computer systems.











7.19.9Average duration of current practice (years)
39.843.4Average age of participants (years)a








aInformation regarding age and years in practice was not collected from 1 family physician participant.
JMIR Hum Factors 2018 | vol. 5 | iss. 3 | e24 | p. 4http://humanfactors.jmir.org/2018/3/e24/
(page number not for citation purposes)
Mercer et alJMIR HUMAN FACTORS
XSL•FO
RenderX
As part of the multidisciplinary framework, we held a 2-day
research meeting where the entire multidisciplinary team
participated in the analysis. Research group members came to
the meeting having individually coded the same 5 interviews.
Through a process of negotiation, individual codes were
rearranged into 81 subthemes and 6 major themes as outlined
below (Table 3). KM and KW recoded the remaining interviews
using the new framework, with no additional themes arising.
The new coding framework placed a more significant focus on
how pharmacist-physician relationships and scopes of practice
affect medication-related decisions (Table 3). We found that
decision-making was influenced by the information, processes,
and communication factors related to EHRs, which, in turn,
were influenced by the physician-pharmacist relationships and
scopes of practice.
Table 3. Themes related to interprofessional medication-related decision-making between physicians and pharmacists.
DescriptionSubthemesTheme
Pharmacists and physicians did not describe IP-SDM in
their practices and acted as unintentional gatekeepers to
medication information. Professionals make decisions based
on their individual understanding of the patient’s situation





• Making the decision
• Assumptions about patients
• Patient communication
• IP-SDM
Pharmacists and physicians often communicate with each
other indirectly through patients, faxes, or receptionists.
Yet, both groups are cautious about the expansion of elec-




• Reasons for health care professionals (HCPs)
to communicate with patients
• Reasons for HCPs to communicate with each
other
• Flow of information
• Communication workarounds
• Method of communication
• Availability
• How to document in the medical or pharmacy
chart
• Risk communication
• Patient as messenger
Pharmacists and physicians require information not acces-
sible through current Web-based health platforms to provide
patient care. Even in situations where the information was
available, it was clear that relationships drove information
sharing. Most critically, physicians required access to infor-
mation about medication adherence, while pharmacists re-
quired clear access to medication indications.
Information exchange between
physicians and pharmacists
• Important information for patient care
• Information detectives
• Data collection and entry
• Multiple users
• Place of access
• Context of data entry
• Adherence
• Information scarcity limits roles
• Design features
• Timeliness
Pharmacists and physicians find that current systems do
not typically align with their decision-making processes
and do not support collaboration in daily workflow.
Process of care • System design (fill and bill)
• Identifying patients in need of care
• Stages of care
• Technology limits practice
• Decision-making
• Workarounds
• Documentation of process
• Workflow bottlenecks
• Prioritization
The workplace and professional boundaries for pharmacists
and physicians are both internally and externally imposed.
This includes how each group negotiates the boundaries
of its job, how each group negotiates its interactions with
each other and with patients, and how relationships, or lack
thereof, impact the ability of each group to carry out its
roles and responsibilities.
Scope of practice • Responsibility to diagnose
• Negotiating role boundaries
• Accountability
• Medication management
• Mentorship and role modeling
• Monitoring
Relationships were strongly influenced by physician loca-
tion, nature of the task, and a power imbalance.
Physician-pharmacist relationship • Physical distance
• Community versus primary care pharmacist
• 5 Ws of shared understanding
• Filling the gap or tailoring
• Building collaborative work environments
• Transactional communication
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In the interviews, we asked about how different treatment
options were presented, how patients’ values were taken into
account, and whether the participant knew about IP-SDM. We
observed that IP-SDM was not an active part of the typical
decision-making process. Rather, we identified a spectrum of
decision-making, where the most common approaches to
decision-making included paternalism and informed
decision-making, as outlined below, rather than IP-SDM.
In the paternalistic decisions that were both described and
witnessed, the physician or pharmacist made a decision because
they “assumed,” “understood,” or “knew” it was the “best”, and
then, they “informed” the patient regarding what the patient
should do. In other words, the physicians or pharmacists
“shared” their final decision rather than sharing the
decision-making process:
I really do consider also the patient's preference or
pre-knowledge or understanding. Have I considered
all the factors; the patient factors, cost factors? That
kind of thing I try to make it so it's sort of like rational
prescribing, thinking is there a reason to give it to
them? [Physician 1205, Family Health Team, Ontario]
During informed decision-making, pharmacists and physicians
focus on educating patients well enough to allow them to make
a decision. The goal is to offer recommendations, help the
patient understand why the HCP offered the recommendation,
and allow the patient to choose whether he or she wants to
pursue the recommended course of action:
I want them to make an informed decision. I want
them to understand what's going on with their health.
I want them to understand what the options are and
why we're pursuing those options. I want them to
make an informed decision about whether they want
to move forward with a particular treatment course
or not and understand the rationale for that.
[Physician 1202, Family Health Team, Ontario]
One of the challenges of informed decision-making is that the
information could “scare” the patient. It is unrealistic for all
patients to become as well educated as an HCP about a medical
decision:
I don’t want to give more information than necessary,
especially if I see that a patient is more anxious
during the beginning of the counselling, and even
more so if the patient doesn't want to take the
medication or is scared to take the medication.
[Pharmacist 1121, Quebec, Independent Pharmacy]
Pharmacists who worked in teams talked of making decisions
with physicians rather than patients:
It was last Wednesday, was the last day that I worked
there, and it was more I help the physician choose
the medication. Not so much the patient themselves.
It was a very complex case and the physician had
asked me to meet with the patient first to do a
medication review appointment. [Pharmacist 1124,
Family Health Team Ontario]
Communication Between Pharmacists and Physicians
Communication between pharmacists and physicians is heavily
dependent on the fax machine. Unlike a phone, faxed documents
provide a written record of an encounter. However, fax machines
are not connected with pharmacist and physician information
systems, reducing the efficiency of their use.
We almost prefer a fax than phone a physician. We
phone if it's an immediate thing, but faxing gives us,
again, the detailed paper, dated and detailed work
that we can keep track of. That's what we try to do
[Pharmacist 1109, Independent Clinic, Nova Scotia]
A common complaint among participants was that the standard
processes to request information from another HCP are flawed.
Pharmacists felt that they were limited by having to wait for a
reply to a fax, and physicians often mentioned waiting until
they had time to track down a pharmacist they trusted. The
notion of a centralized way to communicate information was
met with positive reactions. Being able to access key information
without actively and asynchronously communicating with
another HCP was identified as a way to streamline the sharing
of basic medical information (eg, diagnosis, prescriptions, and
lab results). Communication might then be focused around
sharing meaningful information, such as patient histories or
complex care regimens. Participants were concerned that
information is not properly being communicated and may be
missing or incorrectly documented. Pharmacists reported rarely
being able to get past gatekeepers, such as office staff.
There's the ward clerk who won't let you through to
the doctor. It's really difficult to get a doctor on the
phone unless if they're calling you [Pharmacist 1102,
Independent Pharmacy, Ontario]
At instances where pharmacists are colocated with physicians,
face-to-face interactions have the potential to foster the
development of a trusting relationship. However, even when
pharmacists and physicians are colocated, pharmacists still
negotiate the power differential by modulating communication.
I don't go to a physician and say, “You must do this.”
I say, “This is the problem that this patient is having
on these medications. Here are our options. The
options are A, B, and C. I like A because this, this,
and this. I like B because of this, this, and this. What
do you think we should do?” I never try and tell them
what to do. [Pharmacist 1125, Family Health Team,
Ontario]
Information Exchange Between Pharmacists and
Physicians
Pharmacists and physicians use different pieces of information
to provide patient care. Physicians record diagnostic information,
including physical evaluations and tests, while pharmacists keep
detailed records of medications provided. Most of the
interviewed community pharmacists did not have access to the
reason a medication was prescribed, the diagnostic test, or
laboratory results. They assessed appropriateness and dispensed
medications using the limited information contained on a
prescription or patient recall. Additional or clarifying
information needed to be requested from the physician. Even
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in situations where pharmacists had access to information
through an EHR, issues related to missing information, and the
consequent need to contact a physician to gain access to it, were
mentioned.
Maybe there's some piece of information that we're
missing and that's where you ask questions. If they're
asking for refills too soon then it may be, “Why are
you needing this more than what has been prescribed?
Are you taking more than what was on the instructions
that we have? Has someone told you to take more?”
[Pharmacist 1124, Family Health Team, Ontario]
Pharmacists often were missing information on the reason
medications were prescribed. Not knowing why or how a
prescriber decided on a medication not only limited pharmacists’
ability to properly educate patients about their medications but
also limited their ability to participate in decisions to start,
change, or stop a medication.
I would just say that getting information on the
indication would be one. Trying to find out what
they're taking the medication for and what they're
hoping it's going to do for them would be two of the
first questions. [Pharmacist 1107, Nova Scotia,
Independent Practice]
Physicians were also concerned that pharmacists do not have
sufficient patient information to effectively prescribe,
deprescribe, or assess a patient’s medications. Physicians were
missing information about how a medication is taken after it
was prescribed. Occasionally, there were plans in place to
confirm prescription pick up and adherence, but the absence of
adherence data was a clear gap in information. Both groups
cited that the benefit of an EHR was enabling improved
communication and overall patient care.
We've got a system [to help us keep track of]
adherence. It's a really difficult point, and it's a really
important point that I think we need to look because
it's not good right now. [Physician 1201, Ontario,
Family Health Team]
Process of Care
Pharmacists and physicians follow different processes for
providing care, which are reflected in different information
systems used in their daily workflow. Physicians use clinical
data from physical assessment, lab values, and diagnostic
imaging to make treatment decisions. Their office-based EMRs
support documentation of their patient encounters, assessments
of the information, and prescribing history. In community
pharmacies, pharmacy practice management systems support
dispensing and provide patient information sheets, auxiliary
warning labels, warnings about adherence, and drug interaction
alerts. Even in Alberta and Quebec, where there are
province-wide EHRs that include lab values and dispensing
information, the dispensing information is not integrated into
the physician’s EMR and the clinical information is not
incorporated into the pharmacist’s pharmacy practice
management systems.
My goal is to get my EMR and the pharmacist's EMR
exactly the same and up to date. [Physician 1206,
Family Health Team, Alberta]
The lack of overlap between physician and pharmacist
information systems reinforces the siloed workflows of the two
professions and lack of interoperability between privately-owned
EMRs. However, even when pharmacists and physicians work
on the same system, it can be difficult to mesh the two
decision-making processes. The resulting hybrid can be
inefficient, requiring back-and-forth between the patient and
different HCPs.
I made some recommendations to the physician and
patient, which then the physician discussed with the
patient in her appointment with the patient. We also
discussed, the doctor and I, after, to confirm, yes, this
is what we did, and just to follow-up on the whole
discussion. [Pharmacist 1124, Family Health Team,
Ontario]
Many participants lacked awareness of the decision-making
processes of other HCPs, which left them guessing why certain
decisions were made. Guesswork, thus, becomes the de facto
process, rather than an open and collaborative process. Finally,
even though Alberta pharmacists are able to prescribe and use
a provincial EHR used by physicians, their experiences have
been ultimately similar to the pharmacists in other provinces
who did not have access to an EHR.
Scope of Practice
Scope of practice refers to the internal and external boundaries
placed on pharmacists and physicians. In many provinces, the
scope of pharmacist practice has expanded to include
prescribing, which has traditionally been the physician’s role.
This can result in role friction.
It's been good, all the changes, for sure. […]You just
learn [which physicians] who you can do it with and
who you can't, and then you go with that. [Pharmacist
1114, Independent Pharmacy, Alberta]
In rural areas, pharmacists have more latitude toward full scope
of practice as fewer options for care are available, and they are
more likely to know other local HCPs. Scarcity of services
provides situations that encourage greater collaboration and
partnerships due to availability as well as familiarity with
colleagues.
There’s no full time physician in town…A lot of the
local doctors are very open to our input and actually
will seek it. Nearby doctors are a group who will
cover for each other, and we know them. [Pharmacist
1110, Independent Pharmacy, Nova Scotia]
Ideally, a team-based practice means that the different
professions are more easily able to understand each other’s
roles, including how one profession’s skills can complement
another’s. Physicians generally did not consider pharmacists as
partners in care and rarely mentioned active collaboration.
Yeah. Things are good with my pharmacist and I.
We're still trying to work on enhancing our
relationship but definitely the trust exists there and
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then now it's just kind of more a matter of allowing
some pharmacists to feel like they can do more.
[Physician 1205, Family Health Team, Ontario]
Even in cases where active collaboration was spoken of in a
meaningful and positive way, it was still clear that there were
underlying restrictions; for example, in the above quote, while
the physician spoke about collaboration, the comments qualified
that only some pharmacists should be allowed to feel like they
could do more. Similarly, the physician referred to the
pharmacist team member as “my pharmacist,” creating in and
out groups of pharmacists and reinforcing traditional power
archetypes.
Relationships Between Pharmacists and Physicians
Physician-pharmacist relationships were often influenced by
physical location and institutional context. When pharmacists
and physicians were colocated, particularly when a common
institutional governance was present, such as a family health
team in Ontario, they were able to share a common system of
health records. The face-to-face interactions also allowed the
pharmacists and physicians to establish personal relationships
with each other. Building trusting relationships allowed for
informal collaboration about patient care. Pharmacists often
spoke of feeling like an outsider to care or that they were “…
not wanting to bother” the physicians [Pharmacist 1107, 1108,
1109, 1121]. The limited opportunity for face-to-face
collaboration artificially restricted the pharmacist’s ability to
support the patient.
Pharmacists also often felt that they had to navigate the authority
of physicians when assessing medication, and that, due to their
perceived role in health, they were not able to influence care to
the best of their abilities.
I notified a patient’s physician to a contraindicated
drug given by a patient’s psychiatrist. The physician
didn’t feel comfortable changing the drug, and the
psychiatrist said, well, I'm not changing mine, I have
him on what I want him to be on. The neurologist, I
couldn't get in touch with him, and then the group
home, they were almost a little bit, “we wish you
hadn't put your hands in the pot, there's too many
people trying to mess things up.” It was really
frustrating because there's this clear thing that could
cause harm to the patient, and you almost felt like
you were doing more harm than good by alerting
everyone to it. [Pharmacist 1102, Independent
Pharmacy, Ontario]
Finally, the interviews made it clear that pharmacists’ processes
for working with physicians are not designed to facilitate
collaboration. Rather, they may have evolved as workarounds
that compensate for the strained relationship with the physician.
Most physicians do like subtle language of requesting
as to, “Can you give me the thought behind
prescribing this because we're just not sure, we want
to make sure the patient understands it well or




This project examines how physicians and pharmacists
communicate patient-focused medication information with each
other to inform the design of EHRs for IP-SDM. There is limited
research on how EHRs currently impact IP-SDM and the
potential they have for improving collaboration. We can see
that the limited communication between physicians and
pharmacists is strongly dependent on the relationship between
them. The suboptimal management and use of medication have
already been well documented, suggesting that we may not be
optimally positioned to provide accessible, effective, and
affordable medication management as patient need rises over
the coming decade [33]. Before pharmacists and physicians can
share medication-related decisions with patients, they themselves
need access to comprehensive information. Furthermore, they
must be prepared to share information about decision-making
and to develop strategies for interprofessional collaboration that
do not rely on colocation or a common institutional EMR or
EHR. The findings of this study point to a status quo where
integrated provider medication management and IP-SDM are
an exception rather than the rule in community settings.
Workable solutions to how information is shared are both social
and technical. Most electronic health information systems are
capable of semantic interoperability, where a receiving
information system is able to clearly interpret information in
exactly the same way as the sending information system. Use
of vocabularies, including RxNorm, and structured documents,
such as the Clinical Document Architecture and Fast Healthcare
Interoperability Resources, supports interoperability [34]. As
beneficial as these may be, the competitive market forces the
costs that rarely support this option, despite its popularity among
providers. Despite pharmacists having played an integral role
in delivering high-quality clinical care in hospitals for decades,
this study highlights the slow progress toward integration and
IP-SDM acceptance in the community. Our research supports
the idea that social factors such as professional acceptance,
institutional structures, and trusting versus nontrusting
relationships are more significant barriers to the adoption of
EHRs into patient care compared with technical challenges.
Kannampallil et al [35] have noted that “complex systems can
appear very different, depending on the aspects, granularity,
and circumstances that the researcher chooses to focus on.” By
focusing on the relationship between physicians and pharmacists
in this study, we saw that each health care profession has access
to critical information that the other profession does not (eg,
pharmacists do not have access to information about a
medication’s reason for use and physicians do not have access
to adherence information). These reasons are related to
inadequate systems for health information exchange as well as
missing professional standards that encourage comprehensive
medication information exchange.
Our findings on communication, information, and process
mirrored Bardet et al’s meta-model on physician and community
pharmacist collaboration [36]; they identified that early on in
a collaboration, key elements include trustworthiness and clarity
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around roles. Physicians and pharmacists also need to develop
an interdependence; establish interest, skills, and positive
perceptions; have clear expectations; and build a relationship
that is grounded in trust [37,38]. Open and bidirectional
communication is also important [36]. Our findings add to the
work of Bardet et al by highlighting how the disconnected
computer systems and decision processes limit collaboration
between pharmacists and physicians. All participants were
enthusiastic about the potential for provincial EHRs to improve
information sharing and communication [39]. A well-designed
EHR could also facilitate many components of a successful
collaboration. Specifically, it has the potential to foster IP-SDM
and level the playing field for understanding around information,
process, and communication.
According to a review of IP-SDM by Dogba et al, safe and
high-quality health care depends on increased levels of
collaboration among HCPs and better engagement with patients
[40]. In our study, all participants voiced their support for
IP-SDM in general. However, when it came to giving examples,
only one physician was able to describe an instance of IP-SDM
in practice, and no pharmacists or physicians were able to clearly
articulate a shared vision for IP-SDM. Moreover, participants
had reservations about their patients’ ability to make decisions.
They referenced the notion that HCP training and experience
enable them to know what is “best for the patients.” Patel et al
[41] have referred to this as a “cautious willingness” to
participate in IP-SDM due to fears over patient competence,
motivations, and dishonesty about adherence.
The notion of “cautious willingness” also applies to HCP
collaboration [42]. Physicians are cautious about giving up a
perceived ownership of a patient’s care, and pharmacists are
equally cautious about making physicians feel like they are
trying to take over the care. The reluctance of pharmacists to
embrace a full scope of practice also reflects serious concerns
about missing information. In the interviews, it was clear that
pharmacists perceive themselves as the last gatekeeper of a
patient’s well-being, yet they are unable to perform that function.
Elwyn et al [43] noted that HCPs often miss the second half of
a consultation, where IP-SDM occurs. We would argue that the
second half of the medication-related consultation is where
IP-SDM and the pharmacist belong. Physicians have the unique
expertise to focus on the diagnoses in the first half of the
consultation. Pharmacists, however, have the expertise required
to help the patients understand and choose a treatment option
that is consistent with their needs and preferences. However,
pharmacists cannot act until they have access to the right
information at the right time and have a bidirectional
communication with the physician. Ultimately, research should
evaluate the link between all interactions in the health care
process that impact patient and clinician decision-making.
Strengths and Limitations
As part of a larger mixed methods study, the insights presented
here are derived solely from the interviews of pharmacists and
physicians. Although these analyses reveal perceptions about
and barriers to IP-SDM and collaboration, they do not reflect
a complete analysis of all data collected, specifically the data
collected from patients. However, in the context of gaining a
deep understanding of physician-pharmacist communications
and relationships, this analysis is a critical step in building a
holistic model of IP-SDM related to medication management.
In addition, while the sample includes pharmacists across all 4
provinces, recruitment challenges limited the participation of
physicians in each of the 4 provinces, especially in Nova Scotia.
Given the similarities in policies and practice across Canadian
provinces and the inclusion of a variety of physician
perspectives, we believe this had little to no impact on our
results. Finally, differences in interviewers’ approaches to
semistructured interviews may have led to differing emphasis
on IP-SDM and collaboration. While the benefit of a
multidisciplinary research team is stronger objectivity stemming
from a variety of research, professional, and patient
backgrounds, this study might have been strengthened even
more if the research team had employed prolonged engagement.
Although important, due to interview time constraints, we could
not explore physicians’ perceptions of pharmacists prescribing,
adapting, or cancelling medications; the influence of these
perceptions is suggested to be explored in future research.
Conclusion
Our study shows that until pharmacists can see the reason for
which a medication is prescribed and physicians gain insight
into adherence, neither group will be fully able to work together
to make medication-related decisions collaboratively. The major
barriers to collaboration include poor communication systems
with minimal interinstitutional information exchange, and even
when an EHR exists, competing decision-making processes are
most often present. We identified the potential to build EHRs
that not only better facilitate access to information but also allow
for processes that better accommodate collaborative care and
enable better understanding of the pharmacist’s scope of
practice. Future research should focus on the alignment of EHRs
with interprofessional decision-making process, which can foster
both intra- and interinstitutional collaboration and information
sharing to best support IP-SDM.
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